Skip to main content
Clinical Trials/NL-OMON31353
NL-OMON31353CompletedNot Applicable

Mobilisation of neutrophils and premature photoaging in chronic vitiligenous skin of black skinned patients - Neutrophil mobilisation and premature photoaging in vitiligo / Vitphotoag

niversitair Medisch Centrum Utrecht0 sites12 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
12

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • •Group I and II: adult, male or female, aged 18 years or over; patients with skin phototype VI and vitiligo; the patient must be willing and able to give written informed consent.
  • •Group I specifically: chronic vitiligo, persistant for 10 years or more, localised on sunexposed skin.
  • •Group II specifically: it must be technically possible to determine the minimal erythemal dose.

Exclusion Criteria

  • •sunlight allergy; tendency to hypertrophic scar or keloid formation; history of alcohol or drug abuse; treatment with phototherapy or systemic (immunosuppressive) therapy such as oral steroids and cyclosporin A during the study, or within 24 weeks prior to the study; treatment with oral and local antibiotics; treatment with topical steroids or tar in the tested locations during the last 2 weeks; clinically relevant cardiovascular, gastrointestinal, liver or renal disease and/or unstable metabolic or endocrine disorders; acute or chronic local bacterial, viral or fungal diseases; women of childbearing potential not using reliable contraception; pregnancy or breast feeding; psychiatric disease or history of noncompliance which, in the investigator*s assessment would interfere with appropriate protocol treatment and monitoring.

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Similar Trials